A Pragmatic Framework for Risk-Based Vitamin D Supplementation in Epilepsy Care in Sub-Saharan Africa
Advances in General Practice of Medicine · 20.05.2026 · 7 (1) · 9-15
DOI: 10.25082/agpm.2026.01.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in General Practice of Medicine, online erschienen am 20.05.2026. Verfasst von Hilaire Abwa Lisimo und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Epilepsy remains a major public health challenge in sub-Saharan Africa, where treatment options are often limited to older, low-cost enzyme-inducing antiseizure medications such as phenobarbital, carbamazepine, and phenytoin. Although these medications are essential for seizure control in resource-constrained settings, prolonged use may accelerate vitamin D metabolism and contribute to hypovitaminosis D, impaired bone mineralization, reduced bone mineral density, osteomalacia, and increased fracture risk. Despite these potential complications, vitamin D assessment is rarely integrated into epilepsy care in the region, and evidence regarding the burden of deficiency among people with epilepsy remains limited. This paper proposes a pragmatic framework for risk-based vitamin D supplementation in epilepsy care adapted to sub-Saharan African contexts. Given the limited availability and affordability of serum 25-hydroxyvitamin D testing, routine laboratory-guided screening is often not feasible. We therefore advocate for a clinically oriented risk-stratification approach prioritizing preventive supplementation among patients at highest risk of deficiency and skeletal complications. High-risk groups may include individuals receiving long-term enzyme-inducing antiseizure medications, children and adolescents, older adults, pregnant women, and patients with malnutrition, reduced sunlight exposure, or physical disability. The framework emphasizes integration of low-cost empirical vitamin D supplementation into routine epilepsy services, particularly at the primary-care level. It also highlights the need for context-adapted clinical algorithms, healthcare provider awareness, patient education, and implementation research to evaluate feasibility, safety, and cost-effectiveness in African settings. Integrating bone health into epilepsy management may represent a feasible and scalable strategy to reduce preventable morbidity and improve long-term outcomes among people living with epilepsy in sub-Saharan Africa.
Zitieren
APA
Lisimo, H. A., Mukuku, O., Polepole, F. M., Birindwa, A. M., Malu, C. K. K., & Wembonyama, S. O. (2026). A Pragmatic Framework for Risk-Based Vitamin D Supplementation in Epilepsy Care in Sub-Saharan Africa. Advances in General Practice of Medicine, 7(1), 9-15. https://doi.org/10.25082/agpm.2026.01.002
Vancouver
Lisimo HA, Mukuku O, Polepole FM, Birindwa AM, Malu CKK, Wembonyama SO. A Pragmatic Framework for Risk-Based Vitamin D Supplementation in Epilepsy Care in Sub-Saharan Africa. Advances in General Practice of Medicine. 2026;7(1):9-15. doi:10.25082/agpm.2026.01.002
BibTeX
@article{Lisimo2026,
author = {Lisimo, Hilaire Abwa and Mukuku, Olivier and Polepole, François Maheshe and Birindwa, Archippe Muhandule and Malu, Célestin Kaputu Kalala and Wembonyama, Stanislas Okitotsho},
title = {A Pragmatic Framework for Risk-Based Vitamin D Supplementation in Epilepsy Care in Sub-Saharan Africa},
journal = {Advances in General Practice of Medicine},
year = {2026},
volume = {7},
number = {1},
pages = {9--15},
doi = {10.25082/agpm.2026.01.002}
}
EUVIMED